Gough Bobby, Imam Syed Z, Blough Bruce, Slikker William, Ali Syed F
Neurochemistry Laboratory, Division of Neurotoxicology, National Center for Toxicological Research/FDA, Jefferson, Arkansas 72079, USA.
Ann N Y Acad Sci. 2002 Jun;965:410-20. doi: 10.1111/j.1749-6632.2002.tb04182.x.
Paramethoxyamphetamine (PMA) is a methoxylated phenethylamine derivative that has been used illicitly in Australia since 1994. PMA is also becoming popular at rave parties in the United States. PMA raised concern when a series of fatalities resulted after its use in South Australia, where it was marketed as "ecstasy," which is the colloquial name for MDMA. In the present study, we evaluated the comparative neurotoxicity of substituted amphetamines in rats. Extracellular levels of dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), serotonin (5-HT), and 5-hydroxyindoleacetic acid (5-HIAA) were assayed in the caudate of freely moving rats using microdialysis and HPLC-EC. Dialysates were assayed every 20 minutes for 4 hours after an intraperitoneal (i.p.) injection of PMA (2.5, 5, 10, 20 mg/kg), MDMA (10 and 20 mg/kg), or METH (2.5 mg/kg). METH produced a significant increase in extracellular DA (700%), and significant decreases in extracellular DOPAC and HVA (30% and 50%), with no detectable changes in either 5-HT or 5-HIAA. MDMA produced significant increases in DA (700% at 10 mg/kg and 950% at 20 mg/kg) and decreases in DOPAC (15% for both 10 and 20 mg/kg), and HVA (50% at 10 mg/kg and 35% at 20 mg/kg). MDMA also increased 5-HT (350% at 10, and 575% at 20 mg/kg), and decreased 5-HIAA to 60% for both dose levels. PMA produced no detectable increases in DA at dose levels of 2.5, 5, or 10 mg/kg, but significantly increased DA (975%) at a dose of 20 mg/kg. However, PMA significantly decreased DOPAC at all dose levels (75% at 2.5; 40% at 5; 30% at 10; 10% at 20 mg/kg), with comparable decreases in HVA at all dose levels. PMA also produced significant increases in 5-HT at 10 and 20 mg/kg (350% for both dose levels), with no detectable changes in 5-HT at 2.5 or 5 mg/kg. All dose levels of PMA significantly decreased 5-HIAA (50 to 70%). These data suggest that PMA, like MDMA and METH, is capable of producing dopaminergic and serotonergic neurotoxicity.
对甲氧基苯丙胺(PMA)是一种甲氧基化的苯乙胺衍生物,自1994年以来一直在澳大利亚被非法使用。PMA在美国的锐舞派对上也越来越受欢迎。在南澳大利亚,PMA被作为“摇头丸”销售(摇头丸是MDMA的俗称),使用后导致一系列死亡事件,这引起了人们的关注。在本研究中,我们评估了大鼠体内取代苯丙胺的比较神经毒性。使用微透析和高效液相色谱-电化学检测法,对自由活动大鼠的尾状核中多巴胺(DA)、3,4-二羟基苯乙酸(DOPAC)、高香草酸(HVA)、5-羟色胺(5-HT)和5-羟基吲哚乙酸(5-HIAA)的细胞外水平进行了测定。腹腔注射PMA(2.5、5、10、20毫克/千克)、MDMA(10和20毫克/千克)或甲基苯丙胺(METH,2.5毫克/千克)后,每20分钟对透析液进行一次检测,持续4小时。METH使细胞外DA显著增加(700%),细胞外DOPAC和HVA显著降低(分别为30%和50%),而5-HT或5-HIAA没有可检测到的变化。MDMA使DA显著增加(10毫克/千克时为700%,20毫克/千克时为950%),DOPAC降低(10和20毫克/千克时均为15%),HVA降低(10毫克/千克时为50%,20毫克/千克时为35%)。MDMA还使5-HT增加(10毫克/千克时为350%,20毫克/千克时为575%),两种剂量水平下5-HIAA均降至60%。在2.5、5或10毫克/千克剂量水平下,PMA未使DA有可检测到的增加,但在20毫克/千克剂量时DA显著增加(975%)。然而,PMA在所有剂量水平下均使DOPAC显著降低(2.5毫克/千克时为75%;5毫克/千克时为40%;10毫克/千克时为30%;20毫克/千克时为10%),所有剂量水平下HVA也有类似程度的降低。PMA在10和20毫克/千克时还使5-HT显著增加(两种剂量水平均为350%),在2.5或5毫克/千克时5-HT没有可检测到的变化。PMA的所有剂量水平均使5-HIAA显著降低(50%至70%)。这些数据表明,PMA与MDMA和METH一样,能够产生多巴胺能和5-羟色胺能神经毒性。